IGFBP5 induces apoptosis in mammary epithelial cells (24), breast cancer cells (32) and osteosarcoma cells (33) but prevents apoptosis in neuroblastoma cells (34), C2 myoblasts (35) and human stellate cells (36). Here, IGFBP5 is linked to breast carcinoma.